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Background: Multimorbidity is clearly a major challenge for healthcare systems. However, currently, its magnitude
and impact on healthcare expenditures is still not well known. The objective of this paper is to present an overview
of the prevalence of multimorbidity by deprivation level in the elderly population of the Basque Country.
Methods: We conducted a cross-sectional analysis that included all the inhabitants of the Basque Country aged
65 years and over (N = 452,698). This was based on data from primary care electronic medical records, hospital
admissions, and outpatient care databases, for a 4-year period. The health problems of the patients were identified
from their diagnoses and prescriptions. Multimorbidity was defined as the presence of two or more chronic
diseases out of a list of 47 of the most important and common chronic conditions consistent with the literature. In
addition, we explored socio-economic and demographic variables such as age, sex, and deprivation level.
Results: Multimorbidity was found in 66.13% of the population aged 65 and over and increases with age until
80 years. The prevalence of multimorbidity was higher in deprived (69.94%) than better-off (60.22%) areas. This
pattern of differences between the most and least disadvantaged areas was observed in all age groups and more
marked in female (70.96-59.78%) than in male (68.54-60.86%) populations. In almost all diseases studied (43 out of
47), 90% of patients had been diagnosed with at least one other illness. It was also frequent the coexistence of
mental and physical health problems in the same person and the presence of multiple physical diseases is higher
in patients with mental disease than in the rest of population (74.97% vs. 58.14%).
Conclusion: Multimorbidity is very common among people over 65 years old in the Basque Country, particularly in
unfavourable socioeconomic environments. Given the ageing population, multimorbidity and its consequences
should be taken into account in healthcare policy, organization of care and medical research. Administrative health
databases are readily available sources of a range of information that can be useful for such purposes.
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Multimorbidity is a common problem in aged popula-
tions and has a wide range of individual and societal
consequences. The costs of caring for chronic patients
increase dramatically with the number of comorbidities.
Given the ageing population and the implications of* Correspondence: jon.orueta@osakidetza.net
†Equal contributors
1O+berri, Basque Institute for Healthcare Innovation, Plaza Asua 1, 48150
Sondika, Spain
2Osakidetza, Basque Health Service, Centro de Salud de Astrabudua, Mezo
35, 48950 Erandio, Spain
Full list of author information is available at the end of the article
© 2013 Orueta et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormultimorbidity for patients, their families and caregivers,
and for health systems and societies, policy makers, ad-
ministrators, clinicians and researchers need to explore
innovative approaches, in order to ensure that high quality
care is provided [1,2].
The coexistence of multiple diseases in a single pa-
tient is so common that multimorbidity is now consid-
ered the most prevalent chronic health condition [3],
and a recent systematic review of 41 published studies
worldwide reported a rate of multimorbidity of between
55 and 98% in people aged 65 and older [4].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lation to multimorbidity, such as age and unfavourable
socio-economic conditions [5,6]. However, there are no
universally accepted definitions for chronicity or multi-
morbidity [7] and many studies are based on a list of
diseases the criteria for which have not been clearly
explained [8]. Further, the use of different sources of infor-
mation may lead to different results in terms of prevalence.
These sources include surveys, diagnoses from administra-
tive databases, prescriptions or primary care medical re-
cords. In addition, most studies have included only certain
segments of the population, such as healthcare service users
[6,9], users of healthcare centres taking part in certain
programmes [10], or those whose data meet certain quality
criteria [5,9,11-13]. Hence, it is difficult to establish whether
the dissimilar values for the prevalence of multimorbidity
that have been published are due to differences in the
studied populations or to variations in the methodology
used.
We sought to extend what is known about multi-
morbidity and, to that end, we designed a study employing
a huge administrative database that contains information
covering almost the entire population of the Basque
Country. Taking advantage of and adapting a methodology
already described in the literature [10], we developed a list
of 47 diseases and defined specific criteria in order to con-
sider a disease active in a given patient. The objective of
this study was to assess the prevalence of multimorbidity
in the population above 65 years old, and to explore differ-
ences as a function of sex, age and deprivation level.
Methods
Ethics statement
This study was approved by the Ethics Committee of the
Basque Country.
We used databases that employ an opaque identifier to
ensure patient confidentiality.
Study population
The study population included every person aged 65 and
over who was covered by public health insurance in the
Basque Country on 31st August 2011 and who had been
covered for at least 6 months in the previous year, regard-
less of whether or not they had made any contact with or
use of the Basque Health Service (N = 452,698). Hence,
our dataset is not a representative sample but rather we
observe all the elderly inhabitants served by our health
service, which corresponds to almost the entire elderly
population in the Basque Country.
Scope of the dataset
Data from the present study are derived from the data-
base set up by the Population Stratification Programme
(PREST) of the Basque Health Service. Although thisprogramme began in 2010 with the aim of classifying all
inhabitants of the autonomous region in terms of their
future healthcare needs, the database contains information
collected since 2007. It combines several different sources
of information (primary and specialized health care regis-
ters and census data) and, from these, we obtained data on
the following variables: diagnoses (primary care, specialist
care, and hospitalisation), prescriptions and procedures. A
more detailed description of these variables is available in
a previous publication [14].
Clinical information
In the Basque Health Service, diagnoses of hospital dis-
charges, visits to specialists, and primary medical records
are coded according to the ICD-9-CM system [15], while
the Anatomical Therapeutic Chemical (ATC) [16] coding
system is used for drugs prescribed by primary care doc-
tors. With this information, inhabitants in the Basque
Country are classified annually using Adjusted Clinical
Groups (ACGs), a case mix system –originally developed
by Starfield et al. [17] at Johns Hopkins University- that
enables health problems to be identified from diagnoses
and prescriptions and individuals to be categorized into a
hundred groups according to their healthcare needs and
its costs. Though there could be omissions or errors in
doctors’ notes in the medical records, it is considered that
they provide high-quality information. Notably, in a previ-
ous study, it was found the rates of chronic diseases
estimated using data in administrative databases of the
Basque Country are similar or (in many cases) higher than
those obtained from population surveys [18].
Definition of chronic conditions
With the aim of describing the prevalence of chronic
diseases and multimorbidity, we adopted a list of 47
pathologies, defined by consensus among the research
team. This task was based on adapting two pre-existing
lists, published by other authors: the 40 diseases selected
by Barnett el al. [10] and the conditions considered to
be chronic in the ACG Technical Reference Guide [19].
Barnett and others [10] drew up a list of diseases
based on their impact on patients in terms of need for
chronic treatment, impaired function, reduced quality
of life and risk of future morbidity or mortality. They in-
cluded pathologies from a previous systematic review
[8], the ones contained in the Quality and Outcomes
Framework (QOF) of the UK General Practice contract
and a selection of conditions considered important for
health service planning by NHS Scotland. According to
the characteristics of each disease, they employed different
criteria: the presence of specific Read codes in the patient
medical records, prescription of medications to treat the
condition, or a combination of diagnoses and prescrip-
tions. To avoid including inactive health problems, in
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prescriptions to be considered.
The ACG system identifies patients suffering specific
health problems, by means of ICD-9-CM codes of diagno-
ses registered or medications prescribed. Based on the
clinical characteristics of the condition, diagnoses are also
classified in 264 Expanded Diagnosis Clusters (EDCs) and
drugs into 69 Rx-defined Morbidity Groups (Rx-MGs). In
this case-mix system, a chronic condition is defined as an
alteration that is likely to last longer than 12 months and
to have a negative impact on health or functional status,
and it includes 127 EDCs.
For the purpose of this study, we adapted the list of
Barnett et al. to our clinical data, i.e., we identified the
conditions from EDCs, Rx-MGs, or ICD-9-CM or ATC
codes, instead of British National Formulary or Read
Codes. We also added to this selection a group of 10
relevant health problems from chronic EDCs. Subse-
quently, we omitted three pathologies: on the one hand,
“painful condition”, because this category contains a very
heterogeneous cluster of symptoms and diseases and, on
the other, “attention deficit disorder” and “psychoactive
substance misuse”, due to these diagnoses being very un-
common in the age group under study. Therefore, our
definitive list was composed of 47 morbidities.
Though in most cases it is considered that a person
has a chronic disease because it has been assigned the
corresponding diagnosis (for example, congestive heart
failure), for some illnesses other criteria were applied:
diagnosis or prescription of specific medications (e.g.,
for diabetes mellitus and Parkinson’s); repeated diagnosis
over several years (low back pain); any history of the
diagnosis together with prescription of specific drugs in
the previous year (asthma and epilepsy); diagnosis in the
previous year or repeated prescriptions over several months
(depression and anxiety); or repeated prescriptions to treat
the given health problem (treated dyspepsia). A detailed
description of the methods employed can be found in the
Additional file 1.
In this study, we considered multimorbidity to be the
co-occurrence of two or more health problems in the
same person, this being the definition most widely used in
the literature [20,21]. Nevertheless, given that there is not
a clear consensus on the minimum number of illnesses a
person must have to apply the term multimorbidity
[1,7,22], we also identified the people in our population
with three or more health problems, this being the criter-
ion applied by some other authors [23].
Socio-demographic information
Demographic variables were used (age on the final day
of the study period and sex), along with the geographical
deprivation index and chronic diseases. The deprivation
index based on census tract was used as the socialindicator. A tract is the smallest geographical unit into
which population census data can be broken down, and
these are created according to population size, as well as
geographical and urban criteria. While the number of
inhabitants in each tract varies, the median is around
1,200 per tract. As the tracts are so small, they tend to
be quite homogenous with respect to the type of dwell-
ings. The deprivation index provides a measure of the
socio-economic characteristics of census tracts and is
constructed from the following variables: percentage of
manual workers, unemployment, temporary employ-
ment, and low educational attainment in the population
(people who are illiterate or have not completed primary
education), both overall and also specifically among
young people (inhabitants between 16–29 years of age)
[24]. Although this index is not specific to the elderly, it
provides a measure of the level of access to material and
social resources in a community and has been shown to
be correlated with general rates of mortality. In this study,
we categorised individuals into quintiles by the deprivation
index score, where 1 corresponds to the least and 5 the
most deprived.
Statistical analysis
Data are described using means, frequencies, contin-
gency tables and graphs. Non-parametric tests were used
to compare the mean number of illnesses: the Wilcoxon
Mann–Whitney test, for assessing differences between
the sexes, and the Kruskal-Wallis test, for differences be-
tween levels of deprivation, and age groups, both overall
and stratified by sex. In addition, the chi-square test was
applied to explore differences in the percentage of the
population found to have multimorbidity. All this analysis
was performed using SAS version 9.2 (SAS Institute, Cary,
NC).
Results
In the Basque Country, 452,698 inhabitants are over
65 years and 145,780 over 80 years. This represents,
respectively, 20.0 and 6.4% of the total population. As
would be expected, these percentages are higher in
women (22.6 and 8.2%) than in men (17.3 and 4.6%).
Table 1 presents the distribution of the population by
sex and age groups. The average number of chronic dis-
eases per person in the total elderly population was
found to be 2.65. This value increases with age up to
80 years and is slightly higher in men, but differences
between sexes are not statistically significant (p = 0.682).
However, the disparities are larger in the female popula-
tion, women living in the more deprived neighbourhoods
having the highest mean number of pathologies.
More than half of over 65-year-olds and more than
75% of the population between 80 and 84 years old were
classified as having multimorbidity, because they had at
Table 1 Mean numbers of chronic diseases and percentage of patients with comorbidity in patient groups according
to sex, age and deprivation index quintile
No. of
people
Average number of chronic diseases per patient. Mean (SD)
Deprivation index
Overall 1 2 3 4 5
Population 452,698 2.65 (2.15) 2.37 (2.06) 2.60 (2.10) 2.72 (2.15) 2.73 (2.16) 2.87 (2.23)
Men
Age group (years)
65-69 57,267 2.03 (1.80) 1.82 (1.74) 1.99 (1.74) 2.11 (1.85) 2.10 (1.81) 2.18 (1.88)
70-74 41,649 2.49 (2.00) 2.26 (1.92) 2.46 (1.97) 2.58 (2.04) 2.55 (2.02) 2.59 (2.06)
75-79 42,016 2.98 (2.22) 2.74 (2.18) 2.93 (2.19) 3.05 (2.22) 3.06 (2.25) 3.11 (2.26)
80-84 30,110 3.34 (2.41) 3.10 (2.32) 3.37 (2.39) 3.45 (2.40) 3.35 (2.41) 3.44 (2.50)
85+ 21,516 3.18 (2.57) 2.92 (2.49) 3.19 (2.51) 3.25 (2.60) 3.29 (2.61) 3.29 (2.64)
All Men 192,558 2.67 (2.19) 2.42 (2.12) 2.65 (2.16) 2.75 (2.21) 2.74 (2.21) 2.81 (2.26)
Women
Age group (years)
65-69 62,315 1.97 (1.73) 1.67 (1.61) 1.91 (1.70) 2.04 (1.75) 2.05 (1.75) 2.24 (1.83)
70-74 48,447 2.39 (1.91) 2.07 (1.80) 2.28 (1.84) 2.45 (1.91) 2.49 (1.92) 2.66 (2.03)
75-79 55,224 2.85 (2.10) 2.53 (2.01) 2.73 (2.04) 2.90 (2.09) 2.94 (2.12) 3.13 (2.19)
80-84 45,364 3.20 (2.25) 2.89 (2.19) 3.11 (2.19) 3.27 (2.22) 3.29 (2.26) 3.48 (2.36)
85+ 48,790 2.99 (2.34) 2.72 (2.26) 2.96 (2.29) 3.07 (2.35) 3.06 (2.34) 3.22 (2.45)
All Women 260,140 2.64 (2.11) 2.34 (2.03) 2.56 (2.06) 2.70 (2.11) 2.72 (2.12) 2.91 (2.21)
Differences statistically significant among Deprivation Index groups (P < 0.0001).
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differences between sexes are not significant (p = 0.521).
The coexistence of even more chronic conditions in the
same person is also common, three or more pathologies
being found in 30% of the population at 65 and 60% at
85 years of age. Again, the pattern of differences be-
tween the groups with the most and least favourable
socio-economic status varied between the sexes. While
women showed larger disparities and there was a strong
gradient between these groups (Figure 1), in men dis-
crepancies were less apparent: the lowest prevalences of
multimorbidity were observed in the least disadvantaged,
but there were relatively small differences between the
other groups (Figure 2).
Men and women also had dissimilar patterns of path-
ologies. Although arterial hypertension and diabetes
were found to be highly prevalent in both sexes, in men
there were high rates of prostatic hypertrophy, malig-
nancies, respiratory and cardiac diseases, while degen-
erative bone and joint diseases and mental problems
were more common in females. Table 3 also illustrates
that multimorbidity is very common in patients with any
of the studied diseases. In almost all of them (43 out of
47), 90% of the patients had been diagnosed with at least
one other illness and, in one third of cases, half of the
patients had at least another four health problems.
Table 4 compares the prevalence of physical multi-
morbidity (defined as the presence of two or more non-mental diseases) in patients with concomitant mental
health problems and those without. These prevalences are
higher among people with mental diseases in all age, gen-
der and deprivation index groups, and such differences are
slightly larger in the younger age groups and in those who
suffer less deprivation.
Discussion
Multimorbidity is such a widespread phenomenon in the
elderly population that, in fact, only a small proportion
of chronically ill elders have just one chronic health
problem, while it is very common for them to be diag-
nosed with a constellation of diseases. Overall, we found
that the proportion of patients with multimorbidity in-
creases with age and unfavourable social conditions. It is
also frequent the coexistence of mental and physical
health problems in the same person and the presence of
multiple physical diseases is higher in populations with
mental disease. Even though the pattern of the mean num-
ber of chronic illnesses per person in men and women are,
to some extent, similar, there are notable differences be-
tween the sexes in the prevalence of specific diseases and
the degree to which women and men are affected by social
factors: inequalities between residents of the most and the
least deprived areas are noticeably more prominent in
females than males. Particularly, the groups of women
who live in the least disadvantaged areas reach the same
prevalences of multimorbidity eight years later than those
Table 2 Population with multimorbidity (two or more chronic diseases) by age, sex and deprivation index quintile
All Deprivation index
All 1 2 3 4 5
66.11% (65.97-66.25) 60.22% (59.91-60.54) 65.33% (65.03-65.64) 67.63% (67.33-67.94) 67.86% (67.56-68.16) 69.94% (69.64-70.25)
Sex Age group (years)
Male 65-69 54.94% (54.53-55.35) 49.18% (48.30-50.07) 54.93% (54.04-55.83) 56.69% (55.78-57.59) 56.55% (55.65-57.45) 58.13% (57.16-59.10)
70-74 64.69% (64.23-65.15) 59.38% (58.32-60.44) 64.41% (63.39-65.44) 66.80% (65.78-67.82) 66.10% (65.11-67.09) 66.74% (65.71-67.76)
75-79 72.49% (72.07-72.92) 67.57% (66.53-68.61) 71.54% (70.57-72.50) 73.89% (72.95-74.83) 74.16% (73.26-75.06) 74.85% (73.92-75.77)
80-84 76.77% (76.29-77.25) 73.59% (72.45-74.72) 77.04% (75.99-78.08) 78.48% (77.43-79.53) 77.00% (75.97-78.04) 77.69% (76.61-78.76)
85+ 70.74% (70.13-71.35) 67.13% (65.78-68.49) 71.60% (70.28-72.91) 71.34% (69.98-72.70) 72.18% (70.83-73.52) 71.84% (70.41-73.27)
All 66.06% (65.85-66.27) 60.86% (60.37-61.34) 65.93% (65.46-66.40) 67.61% (67.14-68.07) 67.52% (67.06-67.98) 68.54% (68.06-69.01)
Sex Age group (years)
Female 65-69 53.55% (53.16-53.94) 46.12% (45.28-46.96) 51.87% (51.00-52.74) 55.35% (54.47-56.23) 55.93% (55.06-56.81) 59.84% (58.93-60.74)
70-74 62.92% (62.49-63.35) 55.55% (54.55-56.54) 60.71% (59.73-61.68) 64.34% (63.38-65.31) 65.68% (64.75-66.61) 68.17% (67.25-69.10)
75-79 70.99% (70.61-71.37) 64.71% (63.80-65.61) 69.04% (68.17-69.90) 72.55% (71.70-73.39) 72.80% (71.99-73.62) 75.59% (74.79-76.38)
80-84 76.16% (75.77-76.55) 70.40% (69.48-71.32) 75.27% (74.39-76.15) 78.07% (77.20-78.94) 77.80% (76.94-78.66) 79.64% (78.81-80.47)
85+ 70.66% (70.25-71.06) 66.11% (65.25-66.96) 71.02% (70.15-71.90) 71.95% (71.04-72.87) 72.00% (71.07-72.93) 73.66% (72.73-74.60)
All 66.15% (65.97-66.33) 59.78% (59.37-60.19) 64.89% (64.48-65.30) 67.65% (67.25-68.06) 68.12% (67.72-68.53) 70.96% (70.57-71.36)










































Figure 1 Percentage of women with multimorbidity (at least 2 and at least 3 chronic conditions) by deprivation index.
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is only four years among men.
Although our results are consistent with previous
studies, it is difficult to make comparisons due to the
scope of datasets and the different methodologies. Our
study involved a count of illnesses to identify people
with multimorbidity, which is the method most widely
reported in the literature. However, studies differ in the
number of chronic diseases considered, the definitions
thereof, the populations analysed and the sources of infor-
mation [1]. The definition of multimorbidity itself, in
terms of the number of health problems present, has some
limitations since it does not consider very relevant factors
related to individual disease burden, such as the severity
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Figure 2 Percentage of men with multimorbidity (at least 2 and at lea
corresponds to the most deprived population.between them, that is, whether they co-occur by chance,
one causes another or they have common risk factors [25].
Other authors have described the prevalence of multi-
morbidity increasing with age up to a certain point
where it plateaus. This general pattern was seen in the
population of the Basque Country, but with two peculi-
arities: first, the plateau started at about 80 years old, a
more advanced age than observed in other places [22]
and, second, there was even a slight fall in the preva-
lence of multimorbidity around 90 years of age. Hence,
comparing our results with those found by Barnett et al.
in Scotland [10], we observe a similar mean number of
diseases and prevalence of multimorbidity in groups be-
tween 65 and 84 years, but lower values in the Basque
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Table 3 Prevalence of chronic diseases and comorbidities, in the population aged 65 and over in the Basque Country













N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Hypertension 117907 (53%) 156985 (55%) 274892 (54%) 39725 (14%) 235167 (86%) 173639 (63%) 115512 (42%) 71671 (26%)
Diabetes mellitus 41477 (19%) 43783 (15%) 85260 (17%) 4014 (5%) 81246 (95%) 66366 (78%) 47984 (56%) 31943 (37%)
Degenerative joint disease 17032 (8%) 44950 (16%) 61982 (12%) 3775 (6%) 58207 (94%) 48583 (78%) 35822 (58%) 23981 (39%)
Treated dyspepsia 20726 (9%) 38328 (13%) 59054 (12%) 1825 (3%) 57229 (97%) 49973 (85%) 38925 (66%) 27220 (46%)
Anxiety & other neurotic,
stress-related &
somatoform disorders
15047 (7%) 42496 (15%) 57543 (11%) 4785 (8%) 52758 (92%) 44513 (77%) 33452 (58%) 22900 (40%)
Atrial fibrillation 22726 (10%) 21150 (7%) 43876 (9%) 696 (2%) 43180 (98%) 39171 (89%) 32331 (74%) 24580 (56%)
Depression 9677 (4%) 33376 (12%) 43053 (8%) 1210 (3%) 41843 (97%) 37433 (87%) 29771 (69%) 21390 (50%)
Malignancies 23850 (11%) 18110 (6%) 41960 (8%) 3288 (8%) 38672 (92%) 31849 (76%) 23344 (56%) 15662 (37%)
Glaucoma 16609 (7%) 24265 (8%) 40874 (8%) 2436 (6%) 38438 (94%) 31913 (78%) 23233 (57%) 15429 (38%)
Osteoporosis 2057 (1%) 36559 (13%) 38616 (8%) 3440 (9%) 35176 (91%) 28577 (74%) 20645 (53%) 13791 (36%)
Cerebrovascular disease 16539 (7%) 18155 (6%) 34694 (7%) 1200 (3%) 33494 (97%) 29883 (86%) 24167 (70%) 17792 (51%)





23032 (10%) 10359 (4%) 33391 (7%) 1576 (5%) 31815 (95%) 28036 (84%) 22632 (68%) 16888 (51%)
Ischemic heart disease 21019 (9%) 11185 (4%) 32204 (6%) 365 (1%) 31839 (99%) 28353 (88%) 22650 (70%) 16671 (52%)
Chronic heart disease, others 16661 (7%) 12997 (5%) 29658 (6%) 665 (2%) 28993 (98%) 26786 (90%) 22963 (77%) 18143 (61%)
Hypothyroidism 4108 (2%) 23897 (8%) 28005 (5%) 2227 (8%) 25778 (92%) 20904 (75%) 15138 (54%) 10139 (36%)
Low back pain 8327 (4%) 18224 (6%) 26551 (5%) 1457 (5%) 25094 (95%) 21463 (81%) 16312 (61%) 11176 (42%)
Dementia 7780 (3%) 17134 (6%) 24914 (5%) 1518 (6%) 23396 (94%) 20154 (81%) 15764 (63%) 11516 (46%)
Chronic kidney disease 10430 (5%) 10367 (4%) 20797 (4%) 191 (1%) 20606 (99%) 19245 (93%) 16613 (80%) 13260 (64%)
Heart failure 8434 (4%) 10289 (4%) 18723 (4%) 67 (0%) 18656 (100%) 18201 (97%) 16966 (91%) 14796 (79%)
Deafness, hearing loss 7871 (4%) 10115 (4%) 17986 (4%) 2211 (12%) 15775 (88%) 13006 (72%) 9779 (54%) 6712 (37%)
Asthma (currently treated) 6129 (3%) 11241 (4%) 17370 (3%) 3406 (20%) 13964 (80%) 11729 (68%) 9204 (53%) 6615 (38%)
Blindness & low vision 7150 (3%) 10035 (3%) 17185 (3%) 1239 (7%) 15946 (93%) 13745 (80%) 10681 (62%) 7632 (44%)
Peripheral neuropathy,
neuritis
5030 (2%) 9673 (3%) 14703 (3%) 791 (5%) 13912 (95%) 11931 (81%) 9275 (63%) 6630 (45%)
Diverticular disease of
intestine
5162 (2%) 8534 (3%) 13696 (3%) 442 (3%) 13254 (97%) 12001 (88%) 9835 (72%) 7451 (54%)




3949 (2%) 7606 (3%) 11555 (2%) 629 (5%) 10926 (95%) 9454 (82%) 7347 (64%) 5226 (45%)
Parkinson’s disease 3941 (2%) 5204 (2%) 9145 (2%) 461 (5%) 8684 (95%) 7584 (83%) 5939 (65%) 4270 (47%)
Chromosomal anomalies or
inherited metabolic disorders
4311 (2%) 3593 (1%) 7904 (2%) 595 (8%) 7309 (92%) 6027 (76%) 4440 (56%) 3059 (39%)
Chronic liver or pancreatic
disease
4101 (2%) 3000 (1%) 7101 (1%) 227 (3%) 6874 (97%) 6243 (88%) 5201 (73%) 4092 (58%)
Peripheral vascular disease 4732 (2%) 1269 (0%) 6001 (1%) 104 (2%) 5897 (98%) 5525 (92%) 4771 (80%) 3865 (64%)
Treated constipation 2100 (1%) 3816 (1%) 5916 (1%) 108 (2%) 5808 (98%) 5362 (91%) 4560 (77%) 3536 (60%)
Paralysis or muscular
dystrophy
2701 (1%) 2684 (1%) 5385 (1%) 183 (3%) 5202 (97%) 4841 (90%) 4220 (78%) 3418 (63%)
Schizophrenia, affective
psychosis or bipolar disorder
1487 (1%) 2500 (1%) 3987 (1%) 304 (8%) 3683 (92%) 3163 (79%) 2530 (63%) 1905 (48%)
Bronchiectasis 1582 (1%) 1897 (1%) 3479 (1%) 5 (0%) 3474 (100%) 3265 (94%) 2868 (82%) 2280 (66%)
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Table 3 Prevalence of chronic diseases and comorbidities, in the population aged 65 and over in the Basque Country
(Continued)
Disorders of the immune
system
1327 (1%) 1899 (1%) 3226 (1%) 176 (5%) 3050 (95%) 2710 (84%) 2202 (68%) 1712 (53%)
Irritable bowel syndrome 834 (0%) 2200 (1%) 3034 (1%) 144 (5%) 2890 (95%) 2562 (84%) 2044 (67%) 1464 (48%)
Epilepsy (currently treated) 1395 (1%) 1372 (0%) 2767 (1%) 228 (8%) 2539 (92%) 2153 (78%) 1741 (63%) 1288 (47%)
Psoriasis or eczema 1533 (1%) 1186 (0%) 2719 (1%) 107 (4%) 2612 (96%) 2272 (84%) 1793 (66%) 1254 (46%)
Viral hepatitis 1110 (0%) 1456 (1%) 2566 (1%) 156 (6%) 2410 (94%) 2088 (81%) 1679 (65%) 1266 (49%)
Hematologic chronic
disorders
1048 (0%) 1124 (0%) 2172 (0%) 124 (6%) 2048 (94%) 1856 (85%) 1626 (75%) 1321 (61%)
Alcohol problems 1764 (1%) 372 (0%) 2136 (0%) 109 (5%) 2027 (95%) 1796 (84%) 1472 (69%) 1141 (53%)
Inflammatory bowel disease 974 (0%) 1096 (0%) 2070 (0%) 124 (6%) 1946 (94%) 1673 (81%) 1303 (63%) 941 (45%)
Chronic sinusitis 531 (0%) 901 (0%) 1432 (0%) 126 (9%) 1306 (91%) 1105 (77%) 851 (59%) 600 (42%)
Intellectual disability 742 (0%) 490 (0%) 1232 (0%) 692 (56%) 540 (44%) 258 (21%) 179 (15%) 117 (9%)
Migraine 117 (0%) 652 (0%) 769 (0%) 72 (9%) 697 (91%) 569 (74%) 406 (53%) 259 (34%)
Transplant status 474 (0%) 275 (0%) 749 (0%) 14 (2%) 735 (98%) 691 (92%) 605 (81%) 477 (64%)
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chronic illnesses and variations in risk factors between the
sexes have been described by other authors. For example,
inequalities in diabetes [26] and obesity [27] have been
observed to be larger among women, while disparities in
alcohol abuse [28] and smoking [27] are more marked in
men. In relation to multimorbidity, this phenomenon has
been less well documented and our study demonstrates
that there are also different trends in men and women in
this respect.
Our study differs from others in the literature in that, by
including almost all the inhabitants in the Basque Coun-
try, it avoids the potential bias that could arise by only
using a restricted sample of the population. Furthermore,
we used four years of clinical data from different sources,
which helps to overcome the shortcomings of analysing
any given source in isolation [18]. Estimates of prevalences
of chronic illnesses and multimorbidity obtained from
administrative databases are affected by the length of
the observation period [29]. In particular, it is known
that in a considerable proportion of patients with the
diagnosis of a serious chronic disease entered in their
health record one year, this information does not
appear again in the record the following year [30,31].
An excessively long observation period, however, may
lead to the inclusion of diseases with a prolonged
course but which are not active at the time of the
study. On the other hand, medication records can
provide a list of illnesses that are being treated and, in
some cases, it may be more complete than that derived
from diagnoses [32] but a single prescription might not
reliably indicate the presence of a chronic illness.
Attempting to avoid these problems in this study, we
combined information from several different sources
and employed a method designed to distinguish active
from non-active diseases.Limitations
Nevertheless, our study has certain limitations. Firstly,
administrative databases clearly only contain information
about problems that people report to health services.
Therefore, the prevalence of diseases only reflects attended
morbidity; that is, we cannot detect diseases that are
present but which patients and doctors are unaware of
(a very common situation in certain chronic diseases).
Our observed prevalence is also influenced by other
factors, such as accessibility to healthcare services and
help-seeking behaviour of patients. Even though a pub-
lic health insurance system providing universal cover-
age and financed through taxes is associated with
fewer barriers to healthcare access than other models
of care, the situation is not perfect. Previous studies
have identified a relationship between socio-economic
deprivation and use of health resources in Spain
[33,34] and other countries [35,36] and, in most cases,
the pattern has been pro-poor and pro-rich inequity in
the use of primary and specialised care respectively.
Though recognising that this could have influenced the
recording of some health problems, we believe that it
would not have significantly changed the differences in
prevalence of chronic diseases observed between the
groups.
On the other hand, it could be thought that the high
prevalence of multimorbidity observed would be biased
by the fact that patients affected by a chronic disease
have regular contact with health services and, hence, are
more likely to be diagnosed with other health problems.
While our study cannot rule out this possibility, other
authors have shown that elderly people and patients with
complex health problems are precisely the groups in
which doctors have the most difficulty in coding illnesses,
and that this leads to an under recording of diseases
among these groups [37].





Population with mental health problems Population without mental health problems
% CI % CI
All 22.50% 74.97% (74.70-75.23) 58.14% (57.98-58.30)
Men 14.47% 79.16% (78.68-79.63) 61.28% (61.04-61.51)
Women 28.45% 73.39% (73.07-73.71) 55.36% (55.13-55.59)
Age group (years)
65-69 18.16% 63.27% (62.63-63.92) 46.59% (46.28-46.90)
70-74 19.48% 72.16% (71.49-72.82) 56.71% (56.35-57,07)
75-79 22.78% 78.87% (78.33-79.41) 64.69% (64.35-65.03)
80-84 26.95% 81.53% (80.99-82.06) 69.08% (68.69-69.46)
85+ 28.60% 79.12% (78.56-79.68) 60.90% (60.48-61.33)
Deprivation Index
DI1 21.16% 71.67% (71.05-72.30) 51.67% (51.31-52.03)
DI2 22.13% 73.29% (72.69-73.90) 57.44% (57.08-57.80)
DI3 22.69% 75.89% (75.30-76.48) 59.92% (59.55-60.29)
DI4 22.44% 75.75% (75.17-76.33) 60.29% (59.93-60.65)
DI5 24.25% 78.09% (77.53-78.65) 62.04% (61.67-62.41)
CI Confidence Interval (95%).
Physical multimorbidity was considered the concurrence of two or more chronic non-mental diseases in the same person.
They were considered as Mental health problems: Depression; Anxiety & other neurotic, stress related & somatoform disorders; Alcohol problems; Dementia;
Schizophrenia, affective psychosis or bipolar disorder; Intellectual disability.
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Our results have potential implications for the imple-
mentation of healthcare policies and the organization of
healthcare services. They support the view that an
approach based on considering diseases separately has
many limitations [38] and that it is necessary to con-
sider the implications of multimorbidity for approaches
to treatments [39,40], the evaluation of results, the
organization of healthcare services, and the financial
burden of managing illnesses [41].
People living in more deprived areas have a higher preva-
lence of health problems and a higher multimorbidity
burden. This fact is often not taken into account when
planning the distribution of healthcare resources across
geographical areas [42]. The interrelationship between
poverty and poor health is complex and the associated
mechanisms are not fully understood. Nevertheless, it is
recognised that the characteristics of a neighbourhood,
in relation to the provision of services, environment,
security and social influences over health-related habits,
may affect its inhabitants and, in fact, it has even been
proved that changing address can influence health [43].
Some of these factors may be susceptible to interven-
tions from healthcare services, and should also be con-
sidered in healthcare services management.
The combination of chronic illnesses causes patients a
greater degree of disability than would be expected fromeach disease in isolation, and it is associated with a
lower quality of life, psychological distress, poorer
health outcomes, and a greater risk of mortality [44].
Such patients have specific health care needs [38], re-
quire more complex clinical management and incur
higher health care costs [44].
Multimorbidity is a very complex phenomenon and
not all patients with multiple health problems have the
same characteristics. Therefore, further research is re-
quired to identify the diverse subgroups of patients with
multimorbidity, in order to implement specific patient-
centred care programmes.
Conclusion
Multimorbidity is very common among the people
65 years of age in the Basque Country and, in fact, very
few patients with a chronic disease have not been diag-
nosed with at least one further chronic health problem.
Although, for all age and sex groups, prevalence of
multimorbidity is higher in unfavourable socioeco-
nomic environments, the patterns are different in male
and female populations, with the differences between
the most and the least disadvantaged groups being
more marked in women than in men. Given the ageing
population, multimorbidity should be taken into ac-
count in healthcare policy, management and medical
research.
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